TechNavio's analysts forecast the
Regenerative Medicine market in the US to grow at a CAGR of 15.83 percent over
the period 2012-2016. One of the key factors contributing to this market growth
is the increasing number of degenerative diseases. The Regenerative Medicine
market in the US has also been witnessing an increasing number of mergers and
acquisitions. However, stringent regulatory approval processes could pose a
challenge to the growth of this market.
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/regenerative-medicine-market-in-the-us-2012-2016
The other vendors mentioned in the
report are Advanced Cell Technology Inc., Athersys Inc., Arteriocyte Inc., Cytori
Therapeutics Inc., CryoLife, Inc., Genzyme Corp., Geron Corp., Integra Life
Sciences Holdings Corp., InVivo Therapeutics, Kensey Nash Corp., Kinetic
Concepts Inc., NeoStem Inc., Osiris Therapeutics Inc., Osteotech Inc., and RTI
Biologics Inc.
Key questions answered in this
report:
- What will the market size be in
2016 and what will be the growth rate?
- What are key market trends?
- What is driving this market?
- What are the challenges to
market growth?
- Who are the key vendors in this
market space?
- What are the market
opportunities and threats faced by key vendors?
- What are the strengths and
weaknesses of each of these key vendors?
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll
Free: 866-997-4948
No comments:
Post a Comment